Correlation Between Serum Ofatumumab Concentrations, Baseline Patient Characteristics and Clinical Outcomes in Patients with Fludarabine-Refractory Chronic Lymphocytic Leukemia (CLL) Treated with Single-Agent Ofatumumab.
Year: 2009
Type: article
Source: Blood
Authors: Anders Österborg, Birgitte Biilmann Ronn, Roxanne C Jewell, Thomas J Kipps, Jiri Mayer, Stephan Stilgenbauer, Cathy D Williams, Andrzej Hellmann, Tadeusz Robak, Richard R Furman, Peter Hillmen, Marek Trneny, Martin JS Dyer, Swami Padmanabhan, Magdalena Piotrowska, Tomas Kozak, Geoffrey Chan, Michael Arning, Nedjad Losic, Randy Davis, Joris Wilms, Charlotte A Russell, William G Wierda
Institutions: Karolinska University Hospital, Genmab (Denmark), University of California San Diego, Moores Cancer Center, University Hospital Brno, Universität Ulm, University Hospital Ulm, Nottingham University Hospitals NHS Trust, Gdańsk Medical University, Medical University of Lodz, Weill Cornell Medicine, St James's University Hospital, Charles University, Leicester Royal Infirmary, Roswell Park Comprehensive Cancer Center, University Hospital Kralovske Vinohrady, GlaxoSmithKline (United States), The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2424784666